Siemens Healthineers · 5 hours ago
POC Portfolio Management & Innovation Lead, Critical Care (Remote)
Siemens Healthineers is a global leader in point of care blood analysis testing solutions. The POC Portfolio Management & Innovation Lead will develop and execute strategic marketing and product management initiatives to enhance the critical care blood gas portfolio, driving growth and profitability for the POC business.
Health CareHealth DiagnosticsMedicalMedical Device
Responsibilities
Define, drive, and deliver strategic roadmap for the POC critical care business segment and its adjacencies throughout the care continuum through organic and inorganic means, including but not limited to the benchtop blood analysis portfolio
Serve as the primary business owner leading the new product development core team as the business lead and customer advocate working closely with functional teams representing R&D, Manufacturing, Quality, Clinical, Regulatory, Sales, Service and Finance
Work closely with POC Strategy organization and serve as the disease state and critical care segment expert to analyze and determine strategic M&A and/or partnership opportunities within the critical care continuum
Define, create and expand the long-term product strategy and roadmap from ideation though end of life via the development of robust Target Product Profiles and business case(s) to quantify financial investment and ROI, including pricing strategies, cost targets, and defined, prioritized customer needs and solution requirements
Develop and maintain sales forecast unit/revenue projections and associated marketing expenses as key inputs into the financial product plan
Develop insights and generate evidence roadmap in support of the product lifecycle to demonstrate clinical, operational, and financial benefits of the product/solution
Support IUO customer evaluations for products in development and continuously assess and communicate feedback to assure the product or solution is meeting customer needs and user requirements
Leverage voice of customer to define strategies and customer needs using a variety of channels including qualitative or quantitative market research, KOL interviews, literature search, customer interactions, and gathering input from field representatives
Perform comprehensive business analysis to establish the roadmap defining end of manufacturing / end of support for products within your portfolio in conjunction with downstream marketing
Be a vocal ambassador for point of care customers worldwide, prioritizing intimate knowledge and understanding of real-world customer clinical, operational, and financial needs and challenges
Collaborate with downstream marketing to launch new portfolio solutions, transitioning from initial development to refinement throughout the product lifecycle
Lead, develop and execute the controlled release plan for new product introductions defining cross functional KPI’s with the core team and country leadership in preparation for full product launch
Collaborate with regional, country leadership and product marketing teams regarding portfolio refinement and additions, including claims expansion, evolving market trends and future product development requirements to help shape portfolio roadmap
Support and equip downstream and clinical marketing to develop product launch materials, product literature compendiums, and any other collaterals needed for sales execution
Partner with field marketing and sales management teams to develop and execute product launch plans and marketing/sales training in key global markets
Identify, analyze, and report on competitive threats and pricing, customer concerns, and market dynamics and trends for the product portfolio to develop appropriate and timely responses for internal and external audiences
Participate in new product demonstrations at major tradeshows and events as needed, previewing new technologies or coaching commercial teams on new portfolio attributes
Qualification
Required
Bachelor's Degree in Business, Engineering, Health Sciences, or related discipline is required
10+ years of experience with at least 5 years of demonstrated experience in upstream marketing, new product development and strategic marketing in the healthcare or life sciences industry
Proven understanding and expertise in disease state management and IVD testing supporting patients and solutions across critical care settings including but not limited to ICU, NICU, CV/OR, Emergency Care
Demonstrated experience in working with various forms of IVD POC technology including proven expertise in multiple forms of testing platforms (e.g. ISE, clinical chemistry, hemostasis, hematology and immunoassay) in addition to pre-analytical device solutions
Proven strength and competency in finance, business case development
Strategy, product lifecycle management, marketing and new product launch experience
Demonstrated in-depth knowledge of the point of care competitive landscape
An extensive knowledge of working with US & international healthcare systems, with deep expertise in at least one major market
Demonstrated ability to work under pressure in a fast-paced environment
Self-motivated, highly organized, and able to prioritize and manage multiple projects simultaneously
Strong problem solving and analytical skills; experience working with data to facilitate product decisions along with working knowledge of Microsoft Excel
Exceptional presentation and communication skills; proficient in making compelling presentations on Microsoft PowerPoint
Willing to travel in the US and/or internationally up to 25%
Preferred
MBA preferred or demonstrated equivalent leadership experience in industry
Benefits
Medical insurance
Dental insurance
Vision insurance
401(k) retirement plan
Life insurance
Long-term and short-term disability insurance
Paid parking/public transportation
Paid time off
Paid sick and safe time
Company
Siemens Healthineers
Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services. It is a sub-organization of Siemens.
Funding
Current Stage
Public CompanyTotal Funding
$2.76BKey Investors
Ontario Together Fund
2021-05-25Grant· $2.5M
2021-03-25Post Ipo Equity· $2.76B
2018-03-16IPO
Leadership Team
Recent News
EIN Presswire
2025-12-25
Company data provided by crunchbase